Safety and Efficacy of Targeted IL-13 Rα2 or B7-H3 UCAR-T for Advanced Glioma

Clinical trial NCT05752877 · UNKNOWN

Trial details

NCT number: NCT05752877
Sponsor: Second Affiliated Hospital of Soochow University
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Advanced Glioma Complication of Chimeric Antigen Receptor (CAR-T) Cell Therapy

Start date: 2021-05-01
Primary completion: 2026-04-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.